Geoffrey Grambau
Pulmonary Disease · Kalamazoo, MINPI 1144324633
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by GSK at 30.2% of the total.
Across 200 payments — averaging $12.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$768
- Boehringer Ingelheim$408
- AstraZeneca$304
- Mylan Specialty L.p.$197
- Genentech USA, Inc.$178
- Grifols USA, LLC$175
- plus $512 from 12 others
What the payments were for
- Food & beverage$2,542100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 90 | $768 |
| Boehringer Ingelheim | 27 | $408 |
| AstraZeneca | 20 | $304 |
| Mylan Specialty L.p. | 11 | $197 |
| Genentech USA, Inc. | 6 | $178 |
| Grifols USA, LLC | 9 | $175 |
| Sunovion Pharmaceuticals Inc. | 16 | $148 |
| Sanofi | 3 | $62 |
| Philips North America LLC | 3 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Advanced Respiratory, Inc | 3 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Insmed, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $12 |
How this compares
$2,542 in reported general payments places this provider in the 60th percentile of 463 pulmonary disease providers in Michigan.
Other pulmonary disease in Kalamazoo
- Meilan HanAnn Arbor$779K
- Njira LugogoAnn Arbor$741K
- Gustavo Cumbo NacheliGrand Rapids$724K
- Gary FergusonLivonia$601K
- Justin OldhamAnn Arbor$392K
- Mounir GhaliWyoming$371K
- Kevin FlahertyAnn Arbor$328K
- Podduturu ReddyPort Huron$324K
- Samuel AllenTroy$287K
- Daniel MaxwellAlpena$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.